ImmunityBio (IBRX) Prepaid Assets (2014 - 2026)

ImmunityBio (IBRX) has 13 years of Prepaid Assets data on file, last reported at $3.0 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $3.0 million, down 86.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (down 86.05% YoY), and the FY2025 annual result was $2.1 million, down 91.05% from the prior year.
• Prepaid Assets advanced to $3.0 million in Q1 2026 per IBRX's latest filing, from $2.1 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $32.9 million in Q3 2025 and troughed at $480000.0 in Q2 2024.
• A 5-year average of $14.0 million and a median of $4.6 million in 2023 frame the typical range for Prepaid Assets.
• On a YoY basis, Prepaid Assets climbed as much as 5213.33% in 2025 and fell as far as 91.05% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $31.5 million in 2022, then dropped by 18.73% to $25.6 million in 2023, then slipped by 6.84% to $23.9 million in 2024, then sank by 91.05% to $2.1 million in 2025, then surged by 41.59% to $3.0 million in 2026.
• Business Quant data shows IBRX's Prepaid Assets at $3.0 million in Q1 2026, $2.1 million in Q4 2025, and $32.9 million in Q3 2025.